机译:与化学疗法相比,Muellerian抑制物质优先抑制人卵巢癌细胞系的干/祖细胞
Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnFlow Cytometry Laboratory,Department of Pathology and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnFlow Cytometry Laboratory,Department of Pathology and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114;
rnAbdominal Imaging and Intervention Division, Massachusetts General Hospital, Boston, MA 02114;
rnVincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
rnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
anthrapyrazolone; chemotherapy resistance; stem/progenitor cell-enriched populations;
机译:阿霉素刺激人卵巢癌干/祖细胞,但被穆勒抑制物质抑制
机译:苗勒氏抑制物质可提高亚临床剂量的化学治疗剂抑制人和小鼠卵巢癌的能力
机译:组蛋白脱乙酰基酶抑制剂panobinostat在人卵巢癌细胞系中表现出与常规化学治疗剂明显的协同作用
机译:有机汀聚醚衍生自抗凝血剂的能力,抑制卵巢,结肠,肺,匍匐,胰腺癌和乳腺癌细胞
机译:使用化疗药物吉西他滨-HCl(Gemzar™)和环加氧酶抑制剂罗非考昔(Vioxx™)在胃肠道细胞系的实体肿瘤球体中进行实验性化学疗法。
机译:与化学疗法相比苗勒氏菌抑制物质优先抑制人卵巢癌细胞系的干/祖细胞
机译:与化学疗法相比,苗勒氏菌抑制物质优先抑制人卵巢癌细胞系的干/祖细胞